First Tazarotene Lotion Treatment for Acne Vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), Now Available to Patients Through Quebec, Ontario, Alberta, Saskatchewan and Federal NIHB Public Drug Plans
LAVAL, QC — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its Canadian dermatology division, one of the largest prescription dermatology health care businesses in Canada, today announced that its new… Read More




